glp-1 in heart failure Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action Early trials of GLP-1 based

By modeling obesity management on principles similar to those of staged cancer or heart failure treatment, the SMI approach offers patients safe, flexible pathways wherein each treatment stage delivers meaningful efficacy and, if needed, a clear roadmap to the next best therapeutic option

Its nephrotoxicity happens via two main mechanisms 1 Direct tubular cell toxicity (the BIG one) Amphotericin B binds to ergosterol in fungal cell membranes creates pores cell death

Some mushrooms also provide zinc and vitamin D and are good sources of fiber

At week 30 the primary HbA1c endpoint was missing for 10%, 7% and 7% of patients and during the trial rescue medication was initiated by 20%, 5% and 4% of patients randomized to placebo, OZEMPIC 0.5 mg and OZEMPIC 1 mg, respectively